Understanding the Interaction Between Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Latest Information Update: 20 Aug 2024
At a glance
- Drugs Apalutamide (Primary) ; Darolutamide (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
Most Recent Events
- 16 Aug 2024 Planned End Date changed from 1 Feb 2025 to 1 Feb 2026.
- 16 Aug 2024 Planned primary completion date changed from 1 Sep 2024 to 1 Sep 2025.
- 13 Feb 2023 Status changed from not yet recruiting to recruiting.